Fridman Eran S, Ginini Lana, Gil Ziv
Rappaport Family Institute for Research in the Medical Sciences, Technion-Israel Institute of Technology, Haifa 31096, Israel.
Head and Neck Institute, The Holy Family Hospital Nazareth, Nazareth 1641100, Israel.
Cells. 2022 Apr 23;11(9):1433. doi: 10.3390/cells11091433.
The tumor microenvironment (TME) includes a network of cancerous and non-cancerous cells, together with associated blood vessels, the extracellular matrix, and signaling molecules. The TME contributes to cancer progression during various phases of tumorigenesis, and interactions that take place within the TME have become targets of focus in cancer therapy development. Extracellular vesicles (EVs) are known to be conveyors of genetic material, proteins, and lipids within the TME. One of the hallmarks of cancer is its ability to reprogram metabolism to sustain cell growth and proliferation in a stringent environment. In this review, we provide an overview of TME EV involvement in the metabolic reprogramming of cancer and stromal cells, which favors cancer progression by enhancing angiogenesis, proliferation, metastasis, treatment resistance, and immunoevasion. Targeting the communication mechanisms and systems utilized by TME-EVs is opening a new frontier in cancer therapy.
肿瘤微环境(TME)包括由癌细胞和非癌细胞组成的网络,以及相关的血管、细胞外基质和信号分子。TME在肿瘤发生的各个阶段促进癌症进展,并且TME内发生的相互作用已成为癌症治疗开发中的重点靶点。细胞外囊泡(EVs)是TME内遗传物质、蛋白质和脂质的传递者。癌症的一个标志是其能够重新编程新陈代谢,以在严苛环境中维持细胞生长和增殖。在本综述中,我们概述了TME EV参与癌症和基质细胞的代谢重编程,其通过增强血管生成、增殖、转移、治疗抗性和免疫逃逸来促进癌症进展。靶向TME-EVs所利用的通讯机制和系统正在开启癌症治疗的新前沿。